Paper40928529
Self-efficacy for cancer self-management in the context of COVID-19: a cross-sectional survey study.
Lawler T and 10 others. Support Care Cancer, 2025. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Self-efficacy for cancer self-management in the context of COVID-19: a cross-sectional survey study. Papers, record 40928529. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40928529
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Self-efficacy for cancer self-management in the context of COVID-19: a cross-sectional survey study.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Self Efficacy | Major topic |
| COVID-19 | Major topic |
| Neoplasms | Major topic |
| Self-Management | Major topic |
| Cancer Survivors | Major topic |
| Humans | |
| Middle Aged | |
| Male | |
| Female | |
| Cross-Sectional Studies | |
| Adult | |
| Aged | |
| Adolescent | |
| Aged, 80 and over | |
| Young Adult | |
| Surveys and Questionnaires |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| UL1 TR002373 | NCATS NIH HHS | United States | UL1TR002373 | PubMed and NIH | NIH RePORTER |
| P30CA014520 | NCI NIH HHS | United States | P30CA014520 | PubMed and NIH | NIH RePORTER |
| UL1TR002373 | National Institutes of Health, United States | UL1TR002373 | PubMed and NIH | NIH RePORTER |
References43
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16444764 | Emotional distress: the sixth vital sign--future directions in cancer care. | Psychooncology | 2006 | https://conductscience.org/library/papers/16444764 | PubMed |
| 2 | 25028218 | Cancer survivors' self-efficacy to self-manage in the year following primary treatment. | J Cancer Surviv | 2015 | https://conductscience.org/library/papers/25028218 | PubMed |
| 3 | 33737160 | Cancer management during the COVID-19 pandemic: Choosing between the devil and the deep blue sea. | Crit Rev Oncol Hematol | 2021 | https://conductscience.org/library/papers/33737160 | PubMed |
| 4 | 40445120 | Cancer treatment and survivorship statistics, 2025. | CA Cancer J Clin | 2025 | https://conductscience.org/library/papers/40445120 | PubMed |
| 5 | 19092553 | Testing a theoretical model of perceived self-efficacy for cancer-related fatigue self-management and optimal physical functional status. | Nurs Res | 2009 | https://conductscience.org/library/papers/19092553 | PubMed |
| 6 | 28122812 | Psychological distress in relation to site specific cancer mortality: pooling of unpublished data from 16 prospective cohort studies. | BMJ | 2017 | https://conductscience.org/library/papers/28122812 | PubMed |
| 7 | 29149118 | Perceived Self-Efficacy: A Concept Analysis for Symptom Management in Patients With Cancer . | Clin J Oncol Nurs | 2017 | https://conductscience.org/library/papers/29149118 | PubMed |
| 8 | 34668569 | Cancer health self-efficacy improvement in a randomized controlled trial. | Cancer | 2022 | https://conductscience.org/library/papers/34668569 | PubMed |
| 9 | 19659666 | Self-efficacy beliefs and levels of anxiety in advanced cancer patients. | Eur J Cancer Care (Engl) | 2010 | https://conductscience.org/library/papers/19659666 | PubMed |
| 10 | 26619042 | Validation of the Self-Efficacy for Managing Chronic Disease Scale: A Scleroderma Patient-Centered Intervention Network Cohort Study. | Arthritis Care Res (Hoboken) | 2016 | https://conductscience.org/library/papers/26619042 | PubMed |
| 11 | 21980014 | Survivors at higher risk for adverse late outcomes due to psychosocial and behavioral risk factors. | Cancer Epidemiol Biomarkers Prev | 2011 | https://conductscience.org/library/papers/21980014 | PubMed |
| 12 | 24028476 | Affect as a mediator between self-efficacy and quality of life among Chinese cancer survivors in China. | Eur J Cancer Care (Engl) | 2014 | https://conductscience.org/library/papers/24028476 | PubMed |
| 13 | 33558139 | Assessing patient risk from cancer and COVID-19: Managing patient distress. | Urol Oncol | 2021 | https://conductscience.org/library/papers/33558139 | PubMed |
| 14 | 37085230 | Lessons Learned from Health Disparities in Coronavirus Disease-2019 in the United States. | Clin Chest Med | 2023 | https://conductscience.org/library/papers/37085230 | PubMed |
| 15 | 32525530 | Management of Cancer and Health After the Clinic Visit: A Call to Action for Self-Management in Cancer Care. | J Natl Cancer Inst | 2021 | https://conductscience.org/library/papers/32525530 | PubMed |
| 16 | 37777804 | Psychometric properties of the self-efficacy scale for chronic disease management (SEMCD-S) in older Colombian adults. | BMC Psychol | 2023 | https://conductscience.org/library/papers/37777804 | PubMed |
| 17 | 28239781 | Validation of the PROMIS® measures of self-efficacy for managing chronic conditions. | Qual Life Res | 2017 | https://conductscience.org/library/papers/28239781 | PubMed |
| 18 | 32767203 | COVID-19 and cancer care: what do international guidelines say? | Med Oncol | 2020 | https://conductscience.org/library/papers/32767203 | PubMed |
| 19 | 37642709 | Cancer management during the COVID-19 world pandemic. | Cancer Immunol Immunother | 2023 | https://conductscience.org/library/papers/37642709 | PubMed |
| 20 | 32472216 | Cancer treatment during COVID-19 pandemic. | Med Oncol | 2020 | https://conductscience.org/library/papers/32472216 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42588359 | A Randomized Controlled Trial: eHealth Interventions for Self-Management and Psychological Coping in Cancer Patients. | Healthcare (Basel) | 2026 | https://conductscience.org/library/papers/42588359 | PubMed |
| 41894303 | Evaluation of the effect of perioperative nursing intervention for esophageal cancer patients based on the ADOPT nursing model. | Medicine (Baltimore) | 2026 | https://conductscience.org/library/papers/41894303 | PubMed |
| 41291154 | Distinctive trajectories of symptom burden, activities of daily living, and self-efficacy among patients with advanced cancer receiving care in an acute palliative care unit: a pilot longitudinal study. | Support Care Cancer | 2025 | https://conductscience.org/library/papers/41291154 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40928529
GET https://conductscience.org/api/papers/v1/40928529/references?page=2